Sericin reduces serum cholesterol in rats and cholesterol uptake into Caco-2 cells.
A cholesterol lowering effect of sericin was investigated both in vivo and in vitro. Rats were dosed with cholesterol with and without sericin for 14 days. Non-high-density lipoprotein (HDL) and total serum cholesterols were reduced in rats fed high-cholesterol diet with all three tested doses of sericin (10, 100, and 1000 mg kg(-1) day(-1)). The potential mechanism of actions was determined by measuring the uptake of radiolabeled cholesterol into differentiated Caco-2 cells and cholesterol solubility in mixed lipid micelles. Concentration of sericin as low as 25 and 50 μg/mL inhibited 30% of cholesterol uptake into Caco-2 cells whereas no effect was found at higher concentration. Cholesterol micellar solubility was reduced in the presence of sericin. This study suggests the cholesterol lowering effect of sericin results from its inhibition of cholesterol absorption in intestinal cells and its reduction of cholesterol solubility in lipid micelles.
Department of Pharmacy Practice and Center of Excellence for Innovation in Chemistry.
Nanteetip
N
Limpeanchob
Kanittaporn
K
Trisat
Acharaporn
A
Duangjai
Waree
W
Tiyaboonchai
Sutatip
S
Pongcharoen
Manote
M
Sutheerawattananonda
D000818:Animals; D000924:Anticholesteremic Agents / Q000008:administration & dosage / Q000494:pharmacology*; D001692:Biological Transport / Q000187:drug effects; D018938:Caco-2 Cells; D002784:Cholesterol / Q000097:blood / Q000378:metabolism*; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D007408:Intestinal Absorption / Q000187:drug effects; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D047030:Sericins / Q000008:administration & dosage / Q000494:pharmacology*
D000924:Anticholesteremic Agents; D047030:Sericins; D002784:Cholesterol